| 1 |
Huang TT, Chen CM, Lan YW, Lin SS, Choo KB, Chong KY. Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human Uterine Sarcoma Cells. Int J Mol Sci 2022;23. [PMID: 36499211 DOI: 10.3390/ijms232314884] [Reference Citation Analysis]
|
| 2 |
Wang P, Yang S, Liu C, Chang W, Lee F, Lee W. Endometrial cancer: Part I. Basic concept. Taiwanese Journal of Obstetrics and Gynecology 2022;61:951-959. [DOI: 10.1016/j.tjog.2022.09.001] [Reference Citation Analysis]
|
| 3 |
Tskhay V, Bazina M, Levanova E, Khorzhevskii V, Mihaylova A, Mileeva I, Khudyakov A, Füllers U, Rogmans C, Friedrich M. Endometriales Low-Grade-Stromasarkom als Zufallsbefund bei sonografischem Verdacht auf ein degenerativ verändertes Myom in der Schwangerschaft. Geburtshilfe Frauenheilkd 2022;82:282-6. [DOI: 10.1055/a-1553-8425] [Reference Citation Analysis]
|
| 4 |
Chiang A, Hsu L. Conservative management of early stage uterine leiomyosarcoma: A case report. Taiwanese Journal of Obstetrics and Gynecology 2022;61:402-3. [DOI: 10.1016/j.tjog.2022.02.040] [Reference Citation Analysis]
|
| 5 |
Maccaroni E, Lunerti V, Agostinelli V, Giampieri R, Zepponi L, Pagliacci A, Berardi R. New Insights into Hormonal Therapies in Uterine Sarcomas. Cancers 2022;14:921. [DOI: 10.3390/cancers14040921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Grcevich LO, O'Connell A, Jabaay MJ, Scott JT. Postmenopausal Uterine Leiomyomas and Chronic Lymphadenopathy: Exploring Epigenetic Changes and Pathophysiology. Cureus 2021;13:e18274. [PMID: 34722052 DOI: 10.7759/cureus.18274] [Reference Citation Analysis]
|
| 7 |
Chiappa V, Interlenghi M, Salvatore C, Bertolina F, Bogani G, Ditto A, Martinelli F, Castiglioni I, Raspagliesi F. Using rADioMIcs and machine learning with ultrasonography for the differential diagnosis of myometRiAL tumors (the ADMIRAL pilot study). Radiomics and differential diagnosis of myometrial tumors. Gynecol Oncol 2021;161:838-44. [PMID: 33867144 DOI: 10.1016/j.ygyno.2021.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Silva MG, Banazol N, Coelho P, Fragata JIG. Metastatic endometrial stromal sarcoma: A rare cause of right-sided intracardiac mass. J Card Surg 2021;36:2143-5. [PMID: 33651415 DOI: 10.1111/jocs.15463] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 9 |
da Costa LT, Dos Anjos LG, Kagohara LT, Torrezan GT, De Paula CAA, Baracat EC, Carraro DM, Carvalho KC. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study. Clinics (Sao Paulo) 2021;76:e2324. [PMID: 33503190 DOI: 10.6061/clinics/2021/e2324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Ali M, Chaudhry ZT, Al-hendy A. Uterine Fibroids in Postmenopausal Women. Modern Management of Uterine Fibroids 2020. [DOI: 10.1017/9781108332798.020] [Reference Citation Analysis]
|
| 11 |
Ulin M, Ali M, Chaudhry ZT, Al-Hendy A, Yang Q. Uterine fibroids in menopause and perimenopause. Menopause 2020;27:238-42. [PMID: 31834160 DOI: 10.1097/GME.0000000000001438] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 12 |
Lawlor H, Ward A, Maclean A, Lane S, Adishesh M, Taylor S, DeCruze SB, Hapangama DK. Developing a Preoperative Algorithm for the Diagnosis of Uterine Leiomyosarcoma. Diagnostics (Basel) 2020;10:E735. [PMID: 32977421 DOI: 10.3390/diagnostics10100735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 13 |
Batra Modi K. Uterine Sarcomas: Review and Update. Recent Advances in Endometrial Cancer 2020. [DOI: 10.1007/978-981-15-5317-2_16] [Reference Citation Analysis]
|
| 14 |
Lee WL, Chan IS, Wang PH. Uterine sarcoma: An unusual but high lethal disease of gynecological malignancies. J Chin Med Assoc 2020;83:213-4. [PMID: 31868858 DOI: 10.1097/JCMA.0000000000000242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Grindstaff SL, DiSilvestro J, Hansen K, DiSilvestro P, Sung CJ, Quddus MR. COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication. Gynecol Oncol Rep 2020;31:100523. [PMID: 31921959 DOI: 10.1016/j.gore.2019.100523] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Ludovisi M, Moro F, Pasciuto T, Di Noi S, Giunchi S, Savelli L, Pascual MA, Sladkevicius P, Alcazar JL, Franchi D, Mancari R, Moruzzi MC, Jurkovic D, Chiappa V, Guerriero S, Exacoustos C, Epstein E, Frühauf F, Fischerova D, Fruscio R, Ciccarone F, Zannoni GF, Scambia G, Valentin L, Testa AC. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma. Ultrasound Obstet Gynecol 2019;54:676-87. [DOI: 10.1002/uog.20270] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 17 |
Zang Y, Dong M, Zhang K, Gao C, Guo F, Wang Y, Xue F. Hormonal therapy in uterine sarcomas. Cancer Med 2019;8:1339-49. [PMID: 30897294 DOI: 10.1002/cam4.2044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 18 |
Tantari M, Barra F, Di Domenico S, Ferraioli D, Vellone VG, De Cian F, Ferrero S. Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas. Expert Opinion on Pharmacotherapy 2019;20:713-23. [DOI: 10.1080/14656566.2019.1571042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Zappacosta R, Fanfani F, Zappacosta B, Sablone F, Pansa L, Liberati M, Rosini S. Uterine Sarcomas: An Updated Overview. Part 1: Smooth Muscle Tumors. Neoplasm 2018. [DOI: 10.5772/intechopen.76772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 20 |
Tsuyoshi H, Yoshida Y. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma. Cancer Sci 2018;109:1743-52. [PMID: 29660202 DOI: 10.1111/cas.13613] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 21 |
Ryś J, Harazin-lechowska A, Kruczak A, Knapczyk K, Vogelgesang M, Mularz K, Rozmus-piętoń M, Stalmach A, Król M, Świątkiewicz I, Ambicka A, Majchrzak P, Halaszka K, Przewoźnik M, Wilk W, Moskal J, Wysocka J, Karolewski K, Blecharz P, Wysocki W. Sarcomas and malignant mixed mesodermal tumours of the uterus – Diagnosis and prognostic significance of selected morphological parameters. diagn lab 2017;53:205-210. [DOI: 10.5604/01.3001.0013.7983] [Reference Citation Analysis]
|
| 22 |
Xiu XX, Wang HL, Yun-Yi L, Fan-Dou K, Jin-Ping H. Endometrial stromal sarcoma in combination with mixed type endometrial carcinomas: A case report and literature review. Medicine (Baltimore) 2017;96:e8928. [PMID: 29245257 DOI: 10.1097/MD.0000000000008928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 23 |
Horng HC, Wen KC, Wang PH, Chen YJ, Yen MS, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review. Taiwan J Obstet Gynecol. 2016;55:472-479. [PMID: 27590366 DOI: 10.1016/j.tjog.2016.04.034] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 24 |
Yen MS, Chen JR, Wang PH, Wen KC, Chen YJ, Ng HT; Taiwan Association of Gynecology Systematic Review Group. Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review. Taiwan J Obstet Gynecol 2016;55:625-34. [PMID: 27751406 DOI: 10.1016/j.tjog.2016.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
